Zobrazeno 1 - 10
of 33
pro vyhledávání: ''
Publikováno v:
World Journal of Cardiology
BACKGROUND The EverProTM (Sahajanand Laser Technology Ltd., India) everolimus-eluting coronary stent system (EES) is a second-generation drug-eluting stent with a biodegradable polymer. AIM To determine the safety and performance of the EverProTM EES
Autor:
Andrea Carisio, Maurizio Centonze, Davide Tore, Marco Gatti, Serena Dell'Aversana, Tommaso D’Angelo, Fatemeh Darvizeh, Riccardo Faletti
Publikováno v:
World Journal of Cardiology
The diagnosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) necessitates documentation of an acute myocardial infarction (AMI), non-obstructive coronary arteries, using invasive coronary angiography or coronary computed tom
Publikováno v:
World Journal of Cardiology
BACKGROUND Cardiac catheterization is among the most performed medical procedures in the modern era. There were sporadic reports indicating that cardiac arrhythmias are common during cardiac catheterization, and there are risks of developing serious
Autor:
Syed Nadeem Hassan Rizvi, Atif Sher Muhammad, Tahir Saghir, Tariq Ashraf, Jawaid Akbar Sial, Musa Karim, Ayaz Mir, Faiza Farooq, Syed Alishan, Naveed Ullah Khan, Ali Ammar
Publikováno v:
World Journal of Cardiology
BACKGROUND Even though percutaneous coronary intervention (PCI) improved the survival of patients with acute myocardial infarction, still multivessel coronary artery disease remains an important factor burdening prognosis and it is being associated w
Publikováno v:
World Journal of Cardiology
BACKGROUND Often in patients with significant three-vessel or left main disease there is coexistent significant peripheral disease rendering them poor candidates for percutaneous left ventricular support during revascularization. Evidence on the mana
Publikováno v:
World Journal of Cardiology. 12:91-96
BACKGROUND: Myocardial bridging (MB) is increasingly recognized to stimulate atherogenesis, which may contribute to an acute coronary syndrome. Stenting the coronary segment with MB has been recognized to have an increased risk of in-stent restenosis
Autor:
Alberto Bouzas-Mosquera, Jesús Peteiro
Publikováno v:
World Journal of Cardiology
Coronary angiography and eventual revascularization have become the most common approaches for patients with acute coronary syndromes. Ischemia detection in this scenario is usually regarded as unnecessary for most of the patients. In fact, current g
Publikováno v:
World Journal of Cardiology
BACKGROUND Biodegradable polymer drug-eluting stents (BP-DES) have shown to reduce restenosis rates and have low rates of stent thrombosis. The present postmarketing surveillance assessed 1-year clinical outcomes of patients who had received NeoHexa
Autor:
Stephen J Leslie, Hilal Mohammed Khan
Publikováno v:
World Journal of Cardiology
BACKGROUND There is a high risk for sudden cardiac death (SCD) in certain patient groups that would not meet criteria for implantable cardioverter defibrillator (ICD) therapy. In conditions such as hypertrophic cardiomyopathy (HCM) there are clear ri
Publikováno v:
World Journal of Cardiology
BACKGROUND Takotsubo cardiomyopathy (TCM) is a transient reversible systolic dysfunction, estimated to be the culprit in 1%-2% of patients presenting with clinical symptoms of acute coronary syndrome (ACS). TCM was previously thought to be indistingu